In a new partnership with the National Center for Global Health and Medicine (NCGM), BlueDot's AI-driven global epidemic intelligence system will help safeguard Japanese citizens and enhance international health programs
TORONTO, July 5, 2023 /PRNewswire-PRWeb/ -- BlueDot Inc., a global leader in infectious disease intelligence, announced today that it has signed an agreement with the National Center for Global Health and Medicine (NCGM) of Japan. The collaboration will draw from BlueDot's strengths in integrating artificial and human intelligence to strengthen Japan's readiness and resilience to outbreaks of known and novel infectious diseases.
Under this new partnership, NCGM will leverage BlueDot's global infectious disease intelligence and subject-matter expertise to identify emerging threats earlier, bolster the efficiency of their global horizon scanning activities, and increase the depth and timeliness of their risk assessments. Together, this partnership will support the creation of effective domestic strategies and policies, support international health and aid partnerships, and support NCGM's breakthrough research projects.
"With over 150 years of experience in healthcare, NCGM understands the interconnected nature of today's global infectious disease challenges, and the opportunities that can be realized through scientific and technological innovation", stated Dr. Kamran Khan, CEO and Founder at BlueDot. "This collaboration will empower NCGM with cutting-edge technology rooted in science, around-the-clock data-driven insights, and the foresight to be able to make critical decisions that contribute to a healthier and more resilient world."
"BlueDot's intelligence will amplify our efforts in combatting global infectious diseases to save lives while also serving as a catalyst to advance our medical research and innovation initiatives", Dr. Norihiro Kokudo, President, at NCGM.
BlueDot tracks more than 120 infectious diseases in 130 languages around the world, providing near real-time alerts along with expert analysis, outbreak risk assessments, and intelligence reports. This intelligence will support the Disease Control and Prevention Center within NCGM and will aid their research, policy development, and infectious disease control and prevention programs.
BlueDot's intelligence platform empowers public and private sector organizations to rapidly identify, understand, and effectively respond to global infectious disease threats. Combining human and artificial intelligence to track the activity of hundreds of infectious diseases and syndromes worldwide, it applies academic data science and deep subject matter expertise to anticipate global spread and impact. BlueDot ensures clients immediately know when important infectious disease threats emerge anywhere in the world, helps them focus on those that matter most to their organization, and empowers them to act swiftly and confidently when needed. Founded in 2013 and used by the City of Chicago, Taiwan CDC, Air Canada and more, BlueDot helps clients make critical decisions with clarity and confidence. Learn more at http://www.bluedot.global.
Jenny Cade, BlueDot, 4163206854, [email protected]